Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), Food-effect of TRK-750
Status:
Completed
Trial end date:
2018-08-31
Target enrollment:
Participant gender:
Summary
This is an exploratory, randomised, double-blind, placebo-controlled, Phase I study to assess
the safety, tolerability, pharmacokinetics, pharmacodynamics and food-effect of single and
multiple, ascending oral doses of TRK-750 in healthy adults and patients with peripheral
neuropathic pain.